APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family members are cytidine deaminases that play crucial roles in innate responses to retrovirus infection. The mechanisms by which some of these enzymes restrict human immunodeficiency virus type 1 (HIV-1) replication have...

Full description

Bibliographic Details
Main Authors: Daniela A. Covino, Cristina Purificato, Laura Catapano, Clementina M. Galluzzo, Maria Cristina Gauzzi, Stefano Vella, Eric Lefebvre, Star Seyedkazemi, Mauro Andreotti, Laura Fantuzzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Immunology
Subjects:
APOBEC3A
APOBEC3G
antiretroviral therapy
cenicriviroc
chronic inflammation
disease progression
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01839/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.01839/full

Similar Items